
Here is a roundup of our members who are actively working to make tests for infectious diseases more accessible and available and are also innovating current treatment methods-even with swimming “microrobots. Apply to Senior Quality Engineer, Senior Financial Analyst. The global market for automated and rapid microbiological tests is valued today at $5.9 billion, and is expected to grow to a valuation of $7.6 billion by 2026. 19 Integrated Molecular Diagnostics jobs available in San Francisco Bay Area, CA on. A recent report says global demand for point of care (POC) testing kits for diseases such as HIV, influenza, and respiratory syncytial virus (RSV) are on the uptick, and that the market for infectious disease testing is expected to increase in value to $4.22 billion by 2028. Select from a broad menu of Aptima and Panther Fusion assays to run on scalable automation that meets your needs today and supports future growth. In addition to the ongoing need for new drug therapies and potential vaccines, the need for testing for a variety of infectious diseases is growing and projected to continue to rise. Panther Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time.


Bay Area News Groups Top Workplaces Award.

While COVID-19 treatments and testing have been a top priority for government agencies and biotech companies the past few years, the recent spread of monkeypox and news of polio being detected in wastewater in New York has brought preventing the spread of infectious diseases to the forefront of public health concerns again. Genetic Engineering and Biotechnology News Top 20 Up-and-Coming Molecular Diagnostics Companies List.
